Advanced Medical Solutions Group (CHIX:AMSL) Shares Outstanding (EOP): 216.4 Mil (As of Dec. 2025)


CHIX:AMSL Advanced Medical Solutions Group PLC CHIX:AMSL
93 GF Score
Price £2.78
GF Value £3.71
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Advanced Medical Solutions Group Shares Outstanding (EOP)?

Advanced Medical Solutions Group CHIX:AMSL +14.17% 93 Shares Outstanding (EOP) is 216.4 Mil as of Dec. 2025. GuruFocus rates CHIX:AMSL with a GF Score™ of 93/100 and a GF Value™ of £3.71 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Advanced Medical Solutions Group's shares outstanding for the quarter that ended in Dec. 2025 was 216.4 Mil.

Advanced Medical Solutions Group's quarterly shares outstanding increased from Jun. 2025 (216.0 Mil) to Dec. 2025 (216.4 Mil). It means Advanced Medical Solutions Group issued new shares from Jun. 2025 to Dec. 2025 .

Advanced Medical Solutions Group's annual shares outstanding increased from Dec. 2024 (214.7 Mil) to Dec. 2025 (216.4 Mil). It means Advanced Medical Solutions Group issued new shares from Dec. 2024 to Dec. 2025 .


Advanced Medical Solutions Group  (CHIX:AMSl) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Advanced Medical Solutions Group Shares Outstanding (EOP) Related Terms


Advanced Medical Solutions Group Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Advanced Medical Solutions Group's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Medical Solutions Group Shares Outstanding (EOP) Chart

Advanced Medical Solutions Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 216.07 216.93 214.13 214.66 216.40

Advanced Medical Solutions Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 214.13 214.43 214.66 216.04 216.40

CHIX:AMSL vs ISRG, BDX, MDLN: Shares Outstanding (EOP) Comparison

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group Shares Outstanding (EOP) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's Shares Outstanding (EOP) falls into.


CHIX:AMSL
93GF Score
Advanced Medical Solutions Group PLC CHIX:AMSL
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advanced Medical Solutions Group Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 216.4 Mil mean?
Advanced Medical Solutions Group (CHIX:AMSL) has a Shares Outstanding (EOP) of 216.4 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Advanced Medical Solutions Group and its competitors.
Is Advanced Medical Solutions Group's Shares Outstanding (EOP) too high?
Advanced Medical Solutions Group's current Shares Outstanding (EOP) is 216.4 Mil. Overall, Advanced Medical Solutions Group has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Advanced Medical Solutions Group's Shares Outstanding (EOP) compare to ISRG and BDX?
Advanced Medical Solutions Group's Shares Outstanding (EOP) of 216.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Devices & Instruments company?
A good Shares Outstanding (EOP) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Advanced Medical Solutions Group and its competitors. Advanced Medical Solutions Group's current Shares Outstanding (EOP) is 216.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Medical Solutions Group stock overvalued right now?
Based on GuruFocus' analysis, Advanced Medical Solutions Group (CHIX:AMSL) is currently considered Modestly Undervalued. The stock's GF Value™ is £3.71, compared to a current price of £2.78 — trading 25.1% below its estimated fair value. The current Shares Outstanding (EOP) is 216.4 Mil. Advanced Medical Solutions Group's overall GF Score™ is 93/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Advanced Medical Solutions Group (CHIX:AMSL), the current Shares Outstanding (EOP) is 216.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Advanced Medical Solutions Group (CHIX:AMSL) Overvalued in 2026?

Based on GuruFocus' analysis, Advanced Medical Solutions Group stock appears to be undervalued. The current stock price of £2.78 is trading 25.1% below its estimated GF Value™ of £3.71. GuruFocus considers Advanced Medical Solutions Group to be Modestly Undervalued.

Key valuation signals for CHIX:AMSL:

  • Shares Outstanding (EOP): 216.4 Mil
  • GF Value™: £3.71 vs. price of £2.78 (25.1% below fair value)
  • GF Score™: 93/100 with 6 warning signs

No single metric tells the full story. See the CHIX:AMSL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Advanced Medical Solutions Group Business Description

Other Exchanges AMS:UKAQA:Germany
Address Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
Advanced Medical Solutions Group PLC is engaged in developing and manufacturing wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical and Woundcare, of which the Surgical segment derives maximum revenue. Geographically, the company operates in the United Kingdom, Germany, France, the rest of Europe, the United States of America, and the rest of the world.
93GF Score

Get the complete analysis for CHIX:AMSL

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£2.78
Price
£3.71
GF Value